Experienced leaders in regulatory affairs and drug development
Provide US and Global Regulatory strategy for development programs.
Act as US Agent to FDA.
Provide High Level Strategic Regulatory Advice to Board of Directors, CEOs, and Senior Management.
Integrate into project teams and adapt to Sponsor ways of working.
Collaborate with teams to proactively solve problems.
Expertise across therapeutic areas and treatment modalities (e.g., small molecules, monoclonal antibodies, bispecific antibodies, ADCs, RNA therapeutics, etc.)
Lead, prepare and implement Health Authority Interactions and Meetings.
Successfully obtain key designations to facilitate development, such as Fast Track Designation, Breakthrough Therapy Designation, Orphan Designation, Rare Pediatric Disease Designation, and Qualified Infectious Disease Product Designations.
Lead all aspects of IND, BLA, and NDA filings and review.
Provide guidance on 505(b)(2) applications.
Obtain Health Authority agreement on US Pediatric Plans/Exclusivity and EU PIPs.
Perform due diligence for companies and/or products.
Develop Global Regulatory Strategic Plans.
Provide leadership for Critical Issue Management with Health Authorities.
Drive initiatives including Label Claims/Labeling Strategy, Promotional Claims.
Review Advertising and Promotional materials.
Perform Regulatory Intelligence.
Advisory Committee preparation.
Represent regulatory on senior management committees for drug development, labeling and pharmacovigilance.
Advice and assist in hiring for regulatory positions, writing job descriptions, and setting up regulatory departments.
Advise and write Regulatory SOPs to ensure compliance.
Medical Writing
Author strategic regulatory documents such as Requests for Fast Track, Breakthrough, Orphan, Rare Pediatric Disease, Qualified Infectious Disease Product Designations.
Develop IND/NDA/BLA/MAA High Level Summaries.
Lead Health Authority briefing package authoring (pre-IND, EOPI, EOPII, pre-NDA/BLA, Scientific Advice).
Write Pediatric Study Plans (PSP) and Pediatric Investigational Plans (PIP).
Develop General Investigational Plan for initial INDs.
Author key study documents including Investigator Brochures, Protocols, Informed Consents, Clinical Study Reports.
Lead authoring of Advisory Committee Briefing Packages.
Support teams in writing Responses to Health Authority Requests.
Write publications.
Regulatory Operations and Submissions
Deliver high quality submissions to Health Authorities
Submit all original applications (IND, NDA, BLA) in eCTD via validated electronic submissions gateway (ESG)
Build eCTD dossiers to enable global submission (e.g., MAA)
Perform submission publishing for all components of applications (e.g., protocol amendments, information amendments, responses to FDA questions, Office of Prescription and Drug Promotion materials)Publish and submit FDA briefing packages
Document publish any document for Health Authority submission in compliance with eCTD standards
Publish and submit Orphan drug applications
Manage regulatory submissions lifecycle
Lead and Manage Submissions to Health Authorities
Advise on Internal Regulatory Operations Structure and Processes
Interact as Regulatory Operations Lead with Vendors
Able to submit to Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Veterinary Medicine (CVM)Electronic Submissions Gateway (ESG)
Publish Investigational Medicinal Product Dossiers (IMPD) and components for Clinical Trial Applications (CTA)